RecruitingPhase 2NCT05748834
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
Sponsor: SCRI Development Innovations, LLC
Bensalem, PA · +7 more sites
1 recruiting breast cancer studies with a site in Bensalem, PA.
Sponsor: SCRI Development Innovations, LLC
Bensalem, PA · +7 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.